Carcinoembryonic antigen and cytokeratin 20 in peritoneal cells of cancer patients: Are we aware of what we are detecting by mRNA examination? [3]

British Journal of Cancer

Volumn 98, Issue 2, 2008, Pages 512-513

  Kowalewska, M ^a   Chechlinska, M ^a   Nowak, R ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 20;

CANCER PATIENT; COLON CANCER; GRANULOCYTE; HUMAN; LETTER; LYMPHOID CELL; PERITONEUM CELL; PERITONEUM LAVAGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER;

CARCINOEMBRYONIC ANTIGEN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATIN-20; NEOPLASMS; PERITONEAL CAVITY; PERITONEAL LAVAGE; PREDICTIVE VALUE OF TESTS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 38549099250     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604189     Document Type: Letter

References (17)

1. Broll R, Weschta M, Windhoevel U, Berndt S, Schwandner O, Roblick U, Schiedeck TH, Schimmelpenning H, Bruch HP, Duchrow M (2001) Prognostic significance of free gastrointestinal tumor cells in peritoneal lavage detected by immunocytochemistry and polymerase chain reaction. Langenbecks Arch Surg 386: 285-292
2. Bustin SA, Siddiqi S, Ahmed S, Hands R, Dorudi S (2004) Quantification of cytokeratin 20, carcinoembryonic antigen and guanylyl cyclase C mRNA levels in lymph nodes may not predict treatment failure in colorectal cancer patients. Int J Cancer 108: 412-417
3. Champelovier P, Mongelard F, Seigneurin D (1999) CK20 gene expression: technical limits for the detection of circulating tumor cells. Anticancer Res 19: 2073-2078
4. Chechlinska M, Kaminska J, Markowska J, Kramar A, Steffen J (2007) Peritoneal fluid cytokines and the differential diagnosis of benign and malignant ovarian tumors and residual/recurrent disease examination. Int J Biol Markers 22: 172-180
5. Crumley AB, McMillan DC, McKernan M, McDonald AC, Stuart RC (2006) Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer. Br J Cancer 94: 637-641
6. Deans DA, Wigmore SJ, de Beaux AC, Paterson-Brown S, Garden OJ, Fearon KC (2007) Clinical prognostic scoring system to aid decision-making in gastro-oesophageal cancer. Br J Surg 94: 1501-1508
7. Goeminne JC, Guillaume T, Salmon M, Machiels JP, D'Hondt V, Symann M (1999) Unreliability of carcinoembryonic antigen (CEA) reverse transcriptase-polymerase chain reaction (RT-PCR) in detecting contaminating breast cancer cells in peripheral blood stem cells due to induction of CEA by growth factors. Bone Marrow Transplant 24: 769-775
8. Hau T (1990) Bacteria, toxins, and the peritoneum. World J Surg 14: 167-175
9. Jung R, Krüger W, Hosch S, Holweg M, Kröger N, Gutensohn K, Wagener C, Neumaier M, Zander AR (1998) Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro. Br J Cancer 78: 1194-1198
10. Jung R, Petersen K, Kruger W, Wolf M, Wagener C, Zander A, Neumaier M (1999) Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes. Br J Cancer 81: 870-873
11. Katsuragi K, Yashiro M, Sawada T, Osaka H, Ohira M, Hirakawa K (2007) Prognostic impact of PCR-based identification of isolated tumour cells in the peritoneal lavage fluid of gastric cancer patients who underwent a curative R0 resection. Br J Cancer 97: 550-556
12. Kowalewska M, Chechlinska M, Markowicz S, Kober P, Nowak R (2006) The relevance of RT-PCR detection of disseminated tumour cells is hampered by the expression of markers regarded as tumour-specific in activated lymphocytes. Eur J Cancer 42: 2671-2674
13. Kruger WH, Jung R, Detlefsen B, Mumme S, Badbaran A, Brandner J, Renges H, Kroger N, Zander AR (2001) Interference of cytokeratin-20 and mammaglobin-reverse-transcriptase polymerase chain assays designed for the detection of disseminated cancer cells. Med Oncol 18: 33-38
14. Olszewski WL, Kubicka U, Tarnowski W, Bielecki K, Ziolkowska A, Wesolowska A (2007) Activation of human peritoneal immune cells in early stages of gastric and colon cancer. Surgery 141: 212-221
15. Schuster R, Max N, Mann B, Heufelder K, Thilo F, Grone J, Rokos F, Buhr HJ, Thiel E, Keilholz U (2004) Quantitative real-time RT-PCR for detection of disseminated tumor cells in peripheral blood of patients with colorectal cancer using different mRNA markers. Int J Cancer 108: 219-227
16. Smerage JB, Hayes DF (2006) The measurement and therapeutic implications of circulating tumour cells in breast cancer. Br J Cancer 94: 8-12
17. Vlems FA, Diepstra JH, Cornelissen IM, Ruers TJ, Ligtenberg MJ, Punt CJ, van Krieken JH, Wobbes T, van Muijen GN (2002) Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue. Mol Pathol 55: 156-163